| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0074 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |